Adenosine Deaminase ADAR1 Increases Gene Expression at the Translational Level by Decreasing Protein Kinase PKR-Dependent eIF-2α Phosphorylation

Journal of Molecular Biology

Volumn 393, Issue 4, 2009, Pages 777-787

  Wang, Ying ^a   Samuel, Charles E ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

ADAR1; eIF 2 phosphorylation; PKR; translational control

Indexed keywords

ADAR1 PROTEIN; ADENOSINE DEAMINASE; INITIATION FACTOR 2ALPHA; PLASMID DNA; PROTEIN KINASE R; UNCLASSIFIED DRUG;

ARTICLE; CONTROLLED STUDY; ENZYME ACTIVATION; GENE EXPRESSION; HELA CELL; HUMAN; HUMAN CELL; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN PHOSPHORYLATION; TRANSLATION REGULATION;

MAMMALIA;

ADENOSINE DEAMINASE; ANIMALS; BACTERIOPHAGE LAMBDA; CELL LINE; EIF-2 KINASE; ENZYME ACTIVATION; EUKARYOTIC INITIATION FACTOR-2; GENE EXPRESSION; HUMANS; PHOSPHORYLATION; PLASMIDS; PROTEIN BIOSYNTHESIS; TRANSFECTION;

EID: 70349843062     PISSN: 00222836     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jmb.2009.08.070     Document Type: Article

References (58)

1. Samuel C.E. Antiviral actions of interferons. Clin. Microbiol. Rev. 14 (2001) 778-809
2. Bass B.L., and Weintraub H. An unwinding activity that covalently modifies its double-stranded RNA substrate. Cell 55 (1988) 1089-1098
3. Wagner R.W., Smith J.E., Cooperman B.S., and Nishikura K. A double-stranded RNA unwinding activity introduces structural alterations by means of adenosine to inosine conversions in mammalian cells and Xenopus eggs. Proc. Natl Acad. Sci. USA 86 (1989) 2647-2651
4. Toth A.M., Zhang P., Das S., George C.X., and Samuel C.E. Interferon action and the double-stranded RNA-dependent enzymes ADAR1 adenosine deaminase and PKR protein kinase. Prog. Nucleic Acid Res. Mol. Biol. 81 (2006) 369-434
5. Rebagliati M.R., and Melton D.A. Antisense RNA injections in fertilized frog eggs reveal an RNA duplex unwinding activity. Cell 48 (1987) 599-605
6. Samuel C.E. RNA editing minireview series. J. Biol. Chem. 278 (2003) 1389-1390
7. Bass B.L. RNA editing by adenosine deaminases that act on RNA. Annu. Rev. Biochem. 71 (2002) 817-846
8. Patterson J.B., and Samuel C.E. Expression and regulation by interferon of a double-stranded-RNA-specific adenosine deaminase from human cells: evidence for two forms of the deaminase. Mol. Cell. Biol. 15 (1995) 5376-5388
9. George C.X., Wagner M.V., and Samuel C.E. Expression of interferon-inducible RNA adenosine deaminase ADAR1 during pathogen infection and mouse embryo development involves tissue-selective promoter utilization and alternative splicing. J. Biol. Chem. 280 (2005) 15020-15028
10. George C.X., and Samuel C.E. Human RNA-specific adenosine deaminase ADAR1 transcripts possess alternative exon 1 structures that initiate from different promoters, one constitutively active and the other interferon inducible. Proc. Natl Acad. Sci. USA 96 (1999) 4621-4626
11. Kim U., Wang Y., Sanford T., Zeng Y., and Nishikura K. Molecular cloning of cDNA for double-stranded RNA adenosine deaminase, a candidate enzyme for nuclear RNA editing. Proc. Natl Acad. Sci. USA 91 (1994) 11457-11461
12. O'Connell M.A., Krause S., Higuchi M., Hsuan J.J., Totty N.F., Jenny A., and Keller W. Cloning of cDNAs encoding mammalian double-stranded RNA-specific adenosine deaminase. Mol. Cell. Biol. 15 (1995) 1389-1397
13. Liu Y., and Samuel C.E. Mechanism of interferon action: functionally distinct RNA-binding and catalytic domains in the interferon-inducible, double-stranded RNA-specific adenosine deaminase. J. Virol. 70 (1996) 1961-1968
14. Athanasiadis A., Placido D., Maas S., Brown B.A., Lowenhaupt K., and Rich A. The crystal structure of the Zbeta domain of the RNA-editing enzyme ADAR1 reveals distinct conserved surfaces among Z-domains. J. Mol. Biol. 351 (2005) 496-507
15. Liu Y., Emeson R.B., and Samuel C.E. Serotonin-2C receptor pre-mRNA editing in rat brain and in vitro by splice site variants of the interferon-inducible double-stranded RNA-specific adenosine deaminase ADAR1. J. Biol. Chem. 274 (1999) 18351-18358
16. Liu Y., and Samuel C.E. Editing of glutamate receptor subunit B pre-mRNA by splice-site variants of interferon-inducible double-stranded RNA-specific adenosine deaminase ADAR1. J. Biol. Chem. 274 (1999) 5070-5077
17. Polson A.G., Bass B.L., and Casey J.L. RNA editing of hepatitis delta virus antigenome by dsRNA-adenosine deaminase. Nature 380 (1996) 454-456
18. Gandy S.Z., Linnstaedt S.D., Muralidhar S., Cashman K.A., Rosenthal L.J., and Casey J.L. RNA editing of the human herpesvirus 8 kaposin transcript eliminates its transforming activity and is induced during lytic replication. J. Virol. 81 (2007) 13544-13551
19. Cattaneo R., Schmid A., Eschle D., Baczko K., ter Meulen V., and Billeter M.A. Biased hypermutation and other genetic changes in defective measles viruses in human brain infections. Cell 55 (1988) 255-265
20. Taylor D.R., Puig M., Darnell M.E., Mihalik K., and Feinstone S.M. New antiviral pathway that mediates hepatitis C virus replicon interferon sensitivity through ADAR1. J. Virol. 79 (2005) 6291-6298
21. Zahn R.C., Schelp I., Utermohlen O., and von L.D. A-to-G hypermutation in the genome of lymphocytic choriomeningitis virus. J. Virol. 81 (2007) 457-464
22. Sadler A.J., and Williams B.R. Structure and function of the protein kinase R. Curr. Top. Microbiol. Immunol. 316 (2007) 253-292
23. Dey M., Cao C., Dar A.C., Tamura T., Ozato K., Sicheri F., and Dever T.E. Mechanistic link between PKR dimerization, autophosphorylation, and eIF2alpha substrate recognition. Cell 122 (2005) 901-913
24. McKenna S.A., Lindhout D.A., Kim I., Liu C.W., Gelev V.M., Wagner G., and Puglisi J.D. Molecular framework for the activation of RNA-dependent protein kinase. J. Biol. Chem. 282 (2007) 11474-11486
25. Samuel C.E. Mechanism of interferon action: phosphorylation of protein synthesis initiation factor eIF-2 in interferon-treated human cells by a ribosome-associated kinase processing site specificity similar to hemin-regulated rabbit reticulocyte kinase. Proc. Natl Acad. Sci. USA 76 (1979) 600-604
26. Harding H.P., Novoa I., Zhang Y., Zeng H., Wek R., Schapira M., and Ron D. Regulated translation initiation controls stress-induced gene expression in mammalian cells. Mol. Cell 6 (2000) 1099-1108
27. Samuel C.E. The eIF-2 alpha protein kinases, regulators of translation in eukaryotes from yeasts to humans. J. Biol. Chem. 268 (1993) 7603-7606
28. Dever T.E. Gene-specific regulation by general translation factors. Cell 108 (2002) 545-556
29. Chen J.J. Regulation of protein synthesis by the heme-regulated eIF2alpha kinase: relevance to anemias. Blood 109 (2007) 2693-2699
30. Kramer G., Cimadevilla J.M., and Hardesty B. Specificity of the protein kinase activity associated with the hemin-controlled repressor of rabbit reticulocyte. Proc. Natl Acad. Sci. USA 73 (1976) 3078-3082
31. Wek R.C. eIF-2 kinases: regulators of general and gene-specific translation initiation. Trends Biochem. Sci. 19 (1994) 491-496
32. Harding H.P., Zhang Y., and Ron D. Protein translation and folding are coupled by an endoplasmic-reticulum-resident kinase. Nature 397 (1999) 271-274
33. Scheper G.C., Proud C.G., and van der Knaap M.S. Defective translation initiation causes vanishing of cerebral white matter. Trends Mol. Med. 12 (2006) 159-166
34. Onoguchi K., Yoneyama M., Takemura A., Akira S., Taniguchi T., Namiki H., and Fujita T. Viral infections activate types I and III interferon genes through a common mechanism. J. Biol. Chem. 282 (2007) 7576-7581
35. Zhang P., and Samuel C.E. Protein kinase PKR plays a stimulus- and virus-dependent role in apoptotic death and virus multiplication in human cells. J. Virol. 81 (2007) 8192-8200
36. Romano P.R., Zhang F., Tan S.L., Garcia-Barrio M.T., Katze M.G., Dever T.E., and Hinnebusch A.G. Inhibition of double-stranded RNA-dependent protein kinase PKR by vaccinia virus E3: role of complex formation and the E3 N-terminal domain. Mol. Cell. Biol. 18 (1998) 7304-7316
37. Zhang P., Jacobs B.L., and Samuel C.E. Loss of protein kinase PKR expression in human HeLa cells complements the vaccinia virus E3L deletion mutant phenotype by restoration of viral protein synthesis. J. Virol. 82 (2008) 840-848
38. Gommans W.M., and Maas S. Characterization of ADAR1-mediated modulation of gene expression. Biochem. Biophys. Res. Commun. 377 (2008) 170-175
39. Kaufman R.J., and Murtha P. Translational control mediated by eucaryotic initiation factor-2 is restricted to specific mRNAs in transfected cells. Mol. Cell. Biol. 7 (1987) 1568-1571
40. Laing K.G., Elia A., Jeffrey I., Matys V., Tilleray V.J., Souberbielle B., and Clemens M.J. In vivo effects of the Epstein-Barr virus small RNA EBER-1 on protein synthesis and cell growth regulation. Virology 297 (2002) 253-269
41. Nie Y., Ding L., Kao P.N., Braun R., and Yang J.H. ADAR1 interacts with NF90 through double-stranded RNA and regulates NF90-mediated gene expression independently of RNA editing. Mol. Cell. Biol. 25 (2005) 6956-6963
42. Davies M.V., Chang H.W., Jacobs B.L., and Kaufman R.J. The E3L and K3L vaccinia virus gene products stimulate translation through inhibition of the double-stranded RNA-dependent protein kinase by different mechanisms. J. Virol. 67 (1993) 1688-1692
43. Li S., and Sen G.C. PACT-mediated enhancement of reporter gene expression at the translational level. J. Interferon Cytokine Res. 23 (2003) 689-697
44. Terenzi F., deVeer M.J., Ying H., Restifo N.P., Williams B.R., and Silverman R.H. The antiviral enzymes PKR and RNase L suppress gene expression from viral and non-viral based vectors. Nucleic Acids Res. 27 (1999) 4369-4375
45. Kaufman R.J., Davies M.V., Pathak V.K., and Hershey J.W. The phosphorylation state of eucaryotic initiation factor 2 alters translational efficiency of specific mRNAs. Mol. Cell. Biol. 9 (1989) 946-958
46. Garcia M.A., Gil J., Ventoso I., Guerra S., Domingo E., Rivas C., and Esteban M. Impact of protein kinase PKR in cell biology: from antiviral to antiproliferative action. Microbiol. Mol. Biol. Rev. 70 (2006) 1032-1060
47. Chiu Y.H., Macmillan J.B., and Chen Z.J. RNA polymerase III detects cytosolic DNA and induces type I interferons through the RIG-I pathway. Cell 138 (2009) 576-591
48. McAllister C.S., and Samuel C.E. The RNA-activated protein kinase enhances the induction of interferon-beta and apoptosis mediated by cytoplasmic RNA sensors. J. Biol. Chem. 284 (2009) 1644-1651
49. He Y., Vogelstein B., Velculescu V.E., Papadopoulos N., and Kinzler K.W. The antisense transcriptomes of human cells. Science 322 (2008) 1855-1857
50. Seila A.C., Calabrese J.M., Levine S.S., Yeo G.W., Rahl P.B., Flynn R.A., et al. Divergent transcription from active promoters. Science 322 (2008) 1849-1851
51. Ishikawa H., and Barber G.N. STING is an endoplasmic reticulum adaptor that facilitates innate immune signalling. Nature 455 (2008) 674-678
52. Ishii K.J., Kawagoe T., Koyama S., Matsui K., Kumar H., Kawai T., et al. TANK-binding kinase-1 delineates innate and adaptive immune responses to DNA vaccines. Nature 451 (2008) 725-729
53. Uematsu S., and Akira S. Toll-like receptors and type I interferons. J. Biol. Chem. 282 (2007) 15319-15323
54. Wang Z., Choi M.K., Ban T., Yanai H., Negishi H., Lu Y., et al. Regulation of innate immune responses by DAI (DLM-1/ZBP1) and other DNA-sensing molecules. Proc. Natl Acad. Sci. USA 105 (2008) 5477-5482
55. Ewert K., Slack N.L., Ahmad A., Evans H.M., Lin A.J., Samuel C.E., and Safinya C.R. Cationic lipid-DNA complexes for gene therapy: understanding the relationship between complex structure and gene delivery pathways at the molecular level. Curr. Med. Chem. 11 (2004) 133-149
56. Weide B., Garbe C., Rammensee H.G., and Pascolo S. Plasmid DNA- and messenger RNA-based anti-cancer vaccination. Immunol. Lett. 115 (2008) 33-42
57. Jayan G.C., and Casey J.L. Inhibition of hepatitis delta virus RNA editing by short inhibitory RNA-mediated knockdown of ADAR1 but not ADAR2 expression. J. Virol. 76 (2002) 12399-12404
58. Bouxsein N.F., McAllister C.S., Ewert K.K., Samuel C.E., and Safinya C.R. Structure and gene silencing activities of monovalent and pentavalent cationic lipid vectors complexed with siRNA. Biochemistry 46 (2007) 4785-4792